Low incidence of thromboembolism in multiple myeloma patients receiving immunomodulatory drugs; a retrospective single-institution analysis-Reference-Cited by-同舟云学术

Low incidence of thromboembolism in multiple myeloma patients receiving immunomodulatory drugs; a retrospective single-institution analysis

Published:2019-01-23 Issue:1 Volume:48 Page:141-148
ISSN:0929-5305
Container-title:Journal of Thrombosis and Thrombolysis
language:en
Short-container-title:J Thromb Thrombolysis

Author:

Takaishi Koji,Tsukamoto Shokichi,Ohwada Chikako,Takeuchi Masahiro,Kawasaki Yohei,Nagai Yurie,Mishina Tatsuzo,Yamazaki Miki,Isshiki Yusuke,Kayamori Kensuke,Kimura Kenji,Hino Yutaro,Oshima-Hasegawa Nagisa,Mitsukawa Shio,Takeda Yusuke,Mimura Naoya,Iseki Tohru,Nakaseko Chiaki,Sakaida Emiko

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Hematology

Link

http://link.springer.com/content/pdf/10.1007/s11239-019-01809-w.pdf

Reference30 articles.

1. Falanga A, Marchetti M (2009) Venous thromboembolism in the hematologic malignancies. J Clin Oncol 27(29):4848–4857. https://doi.org/10.1200/JCO.2009.22.8197

2. Palumbo A, Rajkumar SV, Dimopoulos MA, Richardson PG, San Miguel J, Barlogie B, Harousseau J, Zonder JA, Cavo M, Zangari M, Attal M, Belch A, Knop S, Joshua D, Sezer O, Ludwig H, Vesole D, Blade J, Kyle R, Westin J, Weber D, Bringhen S, Niesvizky R, Waage A, von Lilienfeld-Toal M, Lonial S, Morgan GJ, Orlowski RZ, Shimizu K, Anderson KC, Boccadoro M, Durie BG, Sonneveld P, Hussein MA, International Myeloma Working G (2008) Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma. Leukemia 22(2):414–423. https://doi.org/10.1038/sj.leu.2405062

3. Leebeek FWG (2016) Update of thrombosis in multiple myeloma. Thromb Res 140:S76–S80. https://doi.org/10.1016/s0049-3848(16)30103-7

4. Di Nisio M, Ferrante N, Feragalli B, De Tursi M, Iacobelli S, Cuccurullo F, Porreca E (2011) Arterial thrombosis in ambulatory cancer patients treated with chemotherapy. Thromb Res 127(4):382–383. https://doi.org/10.1016/j.thromres.2010.10.001

5. Libourel EJ, Sonneveld P, van der Holt B, de Maat MP, Leebeek FW (2010) High incidence of arterial thrombosis in young patients treated for multiple myeloma: results of a prospective cohort study. Blood 116(1):22–26. https://doi.org/10.1182/blood-2009-12-257519

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence of thromboembolism and associated factors in multiple myeloma patients treated with immunomodulatory drugs: a retrospective analysis in Belo Horizonte, Brazil;Supportive Care in Cancer;2023-12-16

2. Stratification of Venous Thromboembolism Risk in Multiple Myeloma and Analysis of the Use of Antithrombotic Agents;Journal of Korean Society of Health-System Pharmacists;2023-05-31

3. Multiple myeloma and deep vein thrombosis/pulmonary thromboembolism - incidence and risk factors;Medical review;2022

4. Thromboembolic events and thromboprophylaxis associated with immunomodulators in multiple myeloma patients: a real-life study;Journal of Cancer Research and Clinical Oncology;2021-06-18

5. Aspirin/lenalidomide;Reactions Weekly;2019-07